H.C. Wainwright Downgrades Dicerna Pharmaceuticals (DRNA) to Neutral Following Takeover
Tweet Send to a Friend
H.C. Wainwright analyst Ed Arce downgraded Dicerna Pharmaceuticals (NASDAQ: DRNA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
